TNXP โ€“ Tonix Pharmaceuticals โ€“ 30-Min Long Trade Setup !

137
๐Ÿ“ˆ ๐Ÿš€
๐Ÿ”น Asset: TNXP (NASDAQ)
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Symmetrical Triangle Breakout + Trendline Support

๐Ÿ“Š Trade Plan (Long Position)
โœ… Entry Zone: Above $26.53 (Breakout zone + trendline support)
โœ… Stop-Loss (SL): Below $23.81 (Previous support & trendline base)

๐ŸŽฏ Take Profit Targets
๐Ÿ“Œ TP1: $31.64 (Previous resistance zone)
๐Ÿ“Œ TP2: $37.76 (Major resistance / measured move target)

๐Ÿ“Š Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk (SL Distance):
$26.53 - $23.81 = $2.72 risk per share

๐Ÿ“ˆ Reward to TP1:
$31.64 - $26.53 = $5.11 โ†’ (1.88:1 R/R)
๐Ÿ“ˆ Reward to TP2:
$37.76 - $26.53 = $11.23 โ†’ (4.13:1 R/R)

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Triangle Breakout: Price consolidating and now testing triangle resistance
๐Ÿ“Œ Volume Pick-up Expected: Ideal breakout candidate if volume expands above $26.53
๐Ÿ“Œ Trendline Support Holding: Consistent higher lows with bullish structure
๐Ÿ“Œ Break + Retest Zone: Yellow zone acting as breakout confirmation

โš™๏ธ Trade Execution & Risk Management
๐Ÿ“Š Wait for a 30-min bullish close above $26.53
๐Ÿ“‰ Trailing Stop Strategy:
Move SL to breakeven after hitting TP1

๐Ÿ’ฐ Partial Profit Booking Strategy
โœ” Book 50% at TP1 = $31.64
โœ” Let the rest ride toward TP2 = $37.76
โœ” Trail SL above entry to secure gains

โš ๏ธ Breakout Failure Risk
โŒ Setup invalid if price breaks below $23.81
โŒ Avoid entry without clear breakout close above $26.53

๐Ÿš€ Final Thoughts
โœ” Triangle breakout + trendline support = solid bullish setup
โœ” Reward potential up to 4.13:1 R/R
โœ” Clean structure, strong confluence, manageable risk

๐Ÿ”— #TNXP #NASDAQ #BreakoutTrade #SwingTrading #ProfittoPath #TechnicalSetup #TriangleBreakout #TrendlineSupport #StockTrading #RiskReward #PharmaStocks

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.